Trabectedin and low-dose irinotecan to target EWS::FLI1 in Ewing sarcoma: a phase 1/2 trial.
Phase 1/2 trial design - Population: 37 patients with relapsed/refractory Ewing sarcoma. - Regimen: Trabectedin as a...
Microbiota and immune-related adverse events in cancer immunotherapy.
- Post category:Supportive Oncology
- Reading time:2 mins read
This publication is a narrative review of how tissue-associated microbiomes contribute to immune-related adverse events...
“I am Not Just My Illness”: Daily life experiences and participation of advanced cancer patients in palliative care: A qualitative study.
- Post category:Supportive Oncology
- Reading time:2 mins read
This qualitative study explored how patients with advanced-stage cancer receiving palliative care experience daily life...
Cancer therapy-induced ototoxicity: Current challenges and emerging management strategies.
- Post category:Supportive Oncology
- Reading time:2 mins read
This review article focuses on cochleovestibular toxicity as a major, often under-recognized late effect of cancer treat...
Top advances of the year: Palliative and supportive care in oncology.
- Post category:Supportive Oncology
- Reading time:2 mins read
This article reviews recent progress in palliative and supportive care within oncology, focusing on how to improve timel...
Oncology: What You May Have Missed in 2025.
- Post category:Supportive Oncology
- Reading time:2 mins read
The article is a 2025 overview piece aimed at nononcologists who co-manage patients with cancer. It synthesizes 10 key o...